| Original language | English |
|---|---|
| Pages (from-to) | 683-686 |
| Number of pages | 4 |
| Journal | Nature Immunology |
| Volume | 22 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jun 2021 |
Bibliographical note
Funding Information:We thank all of the speakers for participating in the meeting’s robust discussion on the usefulness of mouse models in lupus research. Additionally, we thank Jose Aragon, Luis Mendez, and the rest of the IT team at the National Cancer Institute (NCI) for their support both prior to and on the day of the meeting. This work was supported by the Intramural Research Program of the Center for Cancer Research, NCI. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the United States Government. Funding support included T32-GM007288 from the National Institute of General Medical Sciences (E.M. and J.A.R.); R21AR076557 (A.D.) and K08AR072791 (D.A.R.) from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (A.D); W81XWH-17-1-0657 from the Department of Defense, Lupus Research Alliance (A.D., S.G., and D.A.R.); R01AI128901 from the National Institute of Allergy & Infectious Diseases (L.M.); and a Burroughs Wellcome Fund Career Award in Medical Sciences (D.A.R.).
Funding
We thank all of the speakers for participating in the meeting’s robust discussion on the usefulness of mouse models in lupus research. Additionally, we thank Jose Aragon, Luis Mendez, and the rest of the IT team at the National Cancer Institute (NCI) for their support both prior to and on the day of the meeting. This work was supported by the Intramural Research Program of the Center for Cancer Research, NCI. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the United States Government. Funding support included T32-GM007288 from the National Institute of General Medical Sciences (E.M. and J.A.R.); R21AR076557 (A.D.) and K08AR072791 (D.A.R.) from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (A.D); W81XWH-17-1-0657 from the Department of Defense, Lupus Research Alliance (A.D., S.G., and D.A.R.); R01AI128901 from the National Institute of Allergy & Infectious Diseases (L.M.); and a Burroughs Wellcome Fund Career Award in Medical Sciences (D.A.R.).
| Funders | Funder number |
|---|---|
| U.S. Department of Defense | |
| National Cancer Institute | T32-GM007288 |
| National Institute of General Medical Sciences | |
| National Institute of Allergy and Infectious Diseases | R01AI128901 |
| National Institute of Arthritis and Musculoskeletal and Skin Diseases | K08AR072791, R21AR076557, W81XWH-17-1-0657 |
| Burroughs Wellcome Fund | |
| Lupus Research Alliance |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver